X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

PRTG

Closed

Portage Biotech Inc

5.89
+0.37 (+6.70%)
Last Update: 01 Jul 2025 23:05:00
Yesterday: 5.52
Day's Range: 5.54 - 5.95
Send
When Written:
 
2.95
Portage Biotech Inc. is a biotechnology company that focuses on the development and commercialization of innovative therapeutics in the field of immunology and oncology. The company's portfolio includes several clinical-stage drug candidates, such as PB272 (neratinib) for the treatment of HER2-positive breast cancer, and PPL-003 for the treatment of psoriasis and other autoimmune diseases. Portage Biotech has a unique business model, which involves acquiring and developing promising drug candidates from academic and research institutions, and partnering with biopharmaceutical companies for further development and commercialization. The company is headquartered in New York City and has operations in Canada, Europe, and Asia. Portage Biotech was founded in 2009 and is publicly traded on the Canadian Securities Exchange under the ticker symbol PBT.U.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X